Beta Bionics, Inc. (BBNX)
15.70
+0.21
(+1.36%)
USD |
NASDAQ |
Nov 06, 16:00
15.74
+0.04
(+0.22%)
After-Hours: 20:00
Beta Bionics Research and Development Expense (Quarterly) : 11.98M for Sept. 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 11.98M |
| June 30, 2026 | 10.24M |
| March 31, 2026 | 10.36M |
| December 31, 2025 | 10.13M |
| September 30, 2025 | 8.195M |
| June 30, 2025 | 8.873M |
| March 31, 2025 | 7.59M |
| Date | Value |
|---|---|
| December 31, 2024 | 9.214M |
| September 30, 2024 | 5.141M |
| June 30, 2024 | 6.35M |
| March 31, 2024 | 5.479M |
| December 31, 2023 | 4.46M |
| September 30, 2023 | 3.854M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | 20.01M |
| Edwards Lifesciences Corp. | 281.40M |
| Intuitive Surgical, Inc. | 408.20M |
| Stryker Corp. | 417.00M |
| Zimmer Biomet Holdings, Inc. | 105.90M |